This database contains information about more than 6,000 publications on autism and related issues.
If you know of any other publications we should list on this page please email info@informationautism.org
Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.
Please use the Search Function to find specific items.
This page shows the results of your search for publications containing the term "Glutamate". See definition (new window)
Erickson C. A. , Chambers J. (2006)
Memantine for disruptive behavior in autistic disorder.
Journal of Clinical Psychiatry
67(6), pp. 1000
Journal of Autism and Developmental Disorders
41(11), pp. 1591-1592.
Targeting neurotensin as a potential novel approach for the treatment of autism.
Journal of Neuroinflammation
(7), pp. 58
Targeting of glycine site on NMDA receptor as a possible new strategy for autism treatment.
Neurochemical Research
36(5), pp. 922-923.
Hampson D. R. , Adusei D. C. , Pacey L. K. K. (2011)
The neurochemical basis for the treatment of autism spectrum disorders and Fragile X syndrome.
Biochemical Pharmacology
81(9), pp. 1078-1086
King B. H. , Bostic J. Q. (2006)
An update on pharmacologic treatments for autism spectrum disorders.
Child and Adolescent Psychiatric Clinics of North America
15(1), pp.161-175
King B. H. et al. (2001)
Journal of the American Academy of Child and Adolescent Psychiatry
40(6), pp. 658-665
Journal of Autism and Developmental Disorders
30(5), pp. 439-445
Advanced pharmacotherapy evidenced by pathogenesis of autism spectrum disorder.
Clinical Psychopharmacology and Neuroscience
Pharmacotherapy of pervasive developmental disorders in children and adolescents.
CNS Drugs
18(14), pp. 1031-1052
The status of pharmacotherapy for autism spectrum disorders.
Expert Opinion on Pharmacotherapy
8(11), pp. 1579-1603
Glutamate antagonists seem to be slightly effective in psychopharmacologic treatment of autism.
Journal of Clinical Psychopharmacology
27(3), pp. 317-318
Journal of Child and Adolescent Psychopharmacology
16(5), pp. 517-552
Posey D. J. , Erickson C. A. , McDougle C. J. (2008)
Developing drugs for core social and communication impairment in autism.
Child and Adolescent Psychiatric Clinics of North America
17(4), pp. 787-801
What's in the pipeline? Drugs in development for autism spectrum disorder.
Neuropsychiatric Disease and Treatment
(10), pp. 371-381.
Woodard C. R. et al. (2005)
The treatment of the behavioral sequelae of autism with dextromethorphan: A case report.
Journal of Autism and Developmental Disorders
35(4), pp. 515-518